drugset / Trial / NCT00717626
Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to test the feasibility of a large-scale clinical trial of once-daily prophylaxis. The secondary objectives are to collect clinical efficacy outcomes so that we can better plan a large-scale study; we will estimate the effect size and variability of effect and resource utilization of once-daily prophylaxis to allow us to set a sample size for a definitive trial.
Timeline
- Start
- 2008-07
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADVATE | Protein / enzyme biologic | 250 iu | — |
| Subject | ADVATE | Protein / enzyme biologic | 500 iu | — |
| Subject | Wilate | Protein / enzyme biologic | 250 iu | — |
| Subject | Wilate | Protein / enzyme biologic | 500 iu | — |